Search Results - "Network I"

Diffusion-Weighted MRI for Predicting Pathologic Complete Response in Neoadjuvant Immunotherapy

Li, Wen, Le, Nu N, Onishi, Natsuko, Newitt, David C, Wilmes, Lisa J, Gibbs, Jessica E, Carmona-Bozo, Julia, Liang, Jiachao, Partridge, Savannah C, Price, Elissa R, Joe, Bonnie N, Kornak, John, Magbanua, Mark Jesus M, Nanda, Rita, LeStage, Barbara, Esserman, Laura J, Group, I-SPY Imaging Working, Network, I-SPY Investigator, Veer, Laura J van’t, Hylton, Nola M

application/pdf

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

O.17 Mutation spectrum of limb-girdle muscular dystrophies by New Generation Sequencing approaches

Savarese, M., Torella, A., Giugliano, T., del Vecchio Blanco, F., di Fruscio, G., Dionisi, M., Iacomino, M., Garofalo, A., Piluso, G., LGMD Network, I. Italian, Nigro, V.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

High affinity CD16 polymorphism associated with reduced risk of severe COVID-19.

Qualls AE; Department of Microbiology and Immunology, UCSF, San Francisco, United States of America., Tsao T; Department of Microbiology and Immunology, UCSF, San Francisco, United States of America., Lui I; Department of Pharmaceutical Chemistry; Department of Cellular and Molecula, UCSF, San Francisco, United States of America., Lim SA; Department of Pharmaceutical Chemistry; Department of Cellular and Molecula, UCSF, San Francisco, United States of America., Su Y; Institute for Systems Biology, Seattle, United States of America., Chen E; Yale University School of Medicine, New Haven, United States of America., Duchen D; Yale University School of Medicine, New Haven, United States of America., Maecker HT; Stanford University School of Medicine, Stanford, United States of America., Kim-Schulze S; Oncological Sciences, Division of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, New York, United States of America., Montgomery RR; Yale University School of Medicine, New Haven, United States of America., Krammer F; Icahn School of Medicine at Mount Sinai, New York, United States of America., Langelier CR; Department of Medicine, UCSF, San Francisco, United States of America., Levy O; Precision Vaccines Program, Boston Children's Hospital, Harvard Medical School, Boston, United States of America., Baden LR; Brigham and Women's Hospital, Harvard Medical School, Boston, United States of America., Melamed E; University of Texas at Austin, Austin, United States of America., Ehrlich LI; University of Texas at Austin, Austin, United States of America., McComsey GA; Case Western Reserve University and University Hospitals of Cleveland, Cleveland, United States of America., Sekaly RP; Case Western Reserve University and University Hospitals of Cleveland, Cleveland, United States of America., Cairns CB; Drexel University, Tower Health Hospital, Philadelphia, United States of America., Haddad EK; Drexel University, Tower Health Hospital, Philadelphia, United States of America., Shaw AC; Yale University School of Medicine, New Haven, United States of America., Hafler DA; Yale University School of Medicine, New Haven, United States of America., Corry DB; Baylor College of Medicine and the Michael E. DeBakey VA Center for Translational Research on Inflammatory Diseases, Houston, United States of America., Kheradmand F; Baylor College of Medicine and the Michael E. DeBakey VA Center for Translational Research on Inflammatory Diseases, Houston, United States of America., Atkinson MA; University of Florida, Gainesville, United States of America., Brakenridge SC; University of Florida, Gainesville, United States of America., Agudelo Higuita NI; Oklahoma University Health Sciences Center, Oklahoma City, United States of America., Metcalf JP; Oklahoma University Health Sciences Center, Oklahoma City, United States of America., Hough CL; Oregon Health & Science University, Portland, United States of America., Messer WB; Oregon Health & Science University, Portland, United States of America., Pulendran B; Stanford University School of Medicine, Stanford, United States of America., Nadeau KC; Stanford University School of Medicine, Stanford, United States of America., Davis MM; Stanford University School of Medicine, Stanford, United States of America., Fernandez-Sesma A; Icahn School of Medicine at Mount Sinai, New York, United States of America., Simon V; Icahn School of Medicine at Mount Sinai, New York, United States of America., Kraft M; University of Arizona, Tucson, United States of America., Bime C; University of Arizona, Tucson, United States of America., Calfee CS; Department of Medicine, UCSF, San Francisco, United States of America., Erle DJ; Department of Medicine, UCSF, San Francisco, United States of America., Schaenmann J; David Geffen School of Medicine at UCLA, Los Angeles, United States of America., Ozonoff A; Clinical and Data Coordinating Center, Boston Children's Hospital, Boston, United States of America., Peters B; La Jolla Institute for Allergy and Immunology, La Jolla, United States of America., Kleinstein SH; Yale University School of Medicine, New Haven, United States of America., Augustine AD; National Institute of Allergy and Infectious Diseases, NIH, Bethesda, United States of America., Diray-Arce J; Clinical and Data Coordinating Center, Boston Children's Hospital, Boston, United States of America., Becker PM; National Institute of Allergy and Infectious Diseases, NIH, Bethesda, United States of America., Rouphael N; Emory School of Medicine, Decatur, United States of America., Network I; IMPACC Network, Boston, United States of America., Goldman JD; Division of Allergy and Infectious Diseases, University of Washington, Seattle, United States of America., Calabrese DR; Department of Medicine, UCSF, San Francisco, United States of America., Heath JR; Institute for Systems Biology, Seattle, United States of America., Wells JA; Department of Pharmaceutical Chemistry; Department of Cellular and Molecula, UCSF, San Francisco, United States of America., Reed EF; David Geffen School of Medicine at UCLA, Los Angeles, United States of America., Lanier LL; Department of Microbiology and Immunology, UCSF, San Francisco, United States of America., Pickering H; David Geffen School of Medicine at UCLA, Los Angeles, United States of America., Aguilar OA; Department of Microbiology and Immunology, UCSF, San Francisco, United States of America.

Journal Article , 2025

Achieving equity in bariatric and metabolic surgery: why do we need new guidelines?

Kow L; Department of GastroIntestinal Surgery, Southern Adelaide Local Health Network I, Flinders Medical Centre, Flinders University South Australia, Adelaide, South Australia, Australia.

Journal Article , 2023

Integrated longitudinal multi-omics study identifies immune programs associated with COVID-19 severity and mortality in 1152 hospitalized participants.

Gygi JP, Maguire C, Patel RK, Shinde P, Konstorum A, Shannon CP, Xu L, Hoch A, Jayavelu ND, Network I, Haddad EK, Reed EF, Kraft M, McComsey GA, Metcalf J, Ozonoff A, Esserman D, Cairns CB, Rouphael N, Bosinger SE, Kim-Schulze S, Krammer F, Rosen LB, van Bakel H, Wilson M, Eckalbar W, Maecker H, Langelier CR, Steen H, Altman MC, Montgomery RR, Levy O, Melamed E, Pulendran B, Diray-Arce J, Smolen KK, Fragiadakis GK, Becker PM, Augustine AD, Sekaly RP, Ehrlich LIR, Fourati S, Peters B, Kleinstein SH, Guan L

Preprint; Journal Article , 2023

Early humoral response to COVID-19 vaccination in patients living with obesity and diabetes in France. The COVPOP OBEDIAB study with results from the ANRS0001S COV-POPART cohort.

Gaborit B; Aix Marseille Univ, INSERM, INRAE, C2VN, Marseille, France; Department of Endocrinology, Metabolic Diseases and Nutrition-ENDO platform, APHM, Marseille, France. Electronic address: benedicte.gaborit@ap-hm.fr., Fernandes S; Support Unit for Clinical Research and Economic Evaluation, Assistance Publique-Hôpitaux de Marseille, 13385 Marseille, France; Aix-Marseille Univ, EA 3279 CEReSS-Health Service Research and Quality of Life Center, Marseille, France., Loubet P; Inserm, F-CRIN, Innovative Clinical Research in Vaccinology Network (I REIVAC), Paris, France; Service des Maladies Infectieuses et Tropicales, CHU de Nîmes, Nîmes, France; INSERM U1047 - Université de Montpellier, Nîmes, France., Ninove L; Unite des Virus Emergents, Aix-Marseille Université, Institut de Recherche pour le Développement 190, Inserm 1207, Institut Hospitalo-Universitaire Méditerranée Infection, Marseille, France., Dutour A; Aix Marseille Univ, INSERM, INRAE, C2VN, Marseille, France; Department of Endocrinology, Metabolic Diseases and Nutrition-ENDO platform, APHM, Marseille, France., Cariou B; Nantes Université, CHU Nantes, CNRS, INSERM, Institut du Thorax, 44000 Nantes, France., Coupaye M; Service des Explorations Fonctionnelles, Centre Intégré de Prise en Charge de l'Obésité (CINFO), Hôpital Louis Mourier (AP-HP), 92700 Colombes, France., Clement K; Department of Nutrition, Pitie-Salpetrière Hospital (AP-HP), Sorbonne University, CRNH-Ile-de-France, Paris, France., Czernichow S; Assistance Publique-Hôpitaux de Paris, Service de Nutrition, Hôpital Européen Georges Pompidou, Centre Spécialisé Obésité Ile-de-France Sud, 75015 Paris, France., Carette C; Assistance Publique-Hôpitaux de Paris, Service de Nutrition, Hôpital Européen Georges Pompidou, Centre Spécialisé Obésité Ile-de-France Sud, 75015 Paris, France; Assistance Publique-Hôpitaux de Paris (AP-HP), Centre d'Investigation Clinique INSERM 1418, Hôpital Européen Georges Pompidou, Paris, France., Resseguier N; Support Unit for Clinical Research and Economic Evaluation, Assistance Publique-Hôpitaux de Marseille, 13385 Marseille, France; Aix-Marseille Univ, EA 3279 CEReSS-Health Service Research and Quality of Life Center, Marseille, France., Esterle L; Univ. Bordeaux, INSERM, MART, UMS 54, F-33000 Bordeaux, France., Kali S; ANRS MIE, Paris, France., Houssays M; Assistance-Publique Hôpitaux de Marseille, Medical Evaluation Department, CIC-CPCET, 13005 Marseille, France., de Lamballerie X; Unite des Virus Emergents, Aix-Marseille Université, Institut de Recherche pour le Développement 190, Inserm 1207, Institut Hospitalo-Universitaire Méditerranée Infection, Marseille, France., Wittkop L; Univ. Bordeaux, INSERM, MART, UMS 54, F-33000 Bordeaux, France; Inria Equipe SISTM, Talence, France; CHU de Bordeaux, Service d'Information Médicale, INSERM, Institut Bergonié, CIC-EC 1401, Bordeaux, France., Launay O; Inserm, F-CRIN, Innovative Clinical Research in Vaccinology Network (I REIVAC), Paris, France; Université Paris Cité; Inserm CIC 1417; Assistance Publique Hôpitaux de Paris, Centre d'investigation clinique Cochin Pasteur, Paris, France., Laville M; Univ Lyon, CarMeN Laboratory, Inserm, Inrae, Université Claude Bernard Lyon-1, Oullins, France; Centre de Recherche en Nutrition Humaine Rhône-Alpes, Univ Lyon, CarMeN Laboratory, Université Claude Bernard Lyon-1, Hospices Civils de Lyon, Cens, Fcrin/force Network, Pierre-Bénite, France.

ANRS0001S COV-POPART study group

Multicenter Study; Journal Article , 2023

Alternative hepatitis B vaccine strategies in healthy non-responders to a first standard vaccination scheme.

Loubet P; Université de Paris, faculté de médecine, Paris, France; Inserm, F-CRIN, Innovative clinical research network (I-REIVAC), Paris, France; Assistance Publique Hopitaux de Paris, CIC Cochin Pasteur, Paris, France., Launay O; Université de Paris, faculté de médecine, Paris, France; Inserm, F-CRIN, Innovative clinical research network (I-REIVAC), Paris, France; Assistance Publique Hopitaux de Paris, CIC Cochin Pasteur, Paris, France. Electronic address: odile.launay@aphp.fr.

Journal Article; Comment , 2020

The subset of patients with acute heart failure able to secrete relaxin-2 at pregnancy concentrations could have a longer survival: a pilot study.

Miró Ò; a Department of Emergency , Hospital Clínic, Barcelona; 'Emergencies: processes and pathologies' Research Group, IDIBAPS, University of Barcelona , Barcelona , Catalonia , Spain.; b The Global REsearch on Acute conditions Team (GREAT) network., Herrero-Puente P; c Department of Emergency , Hospital Universitario Central de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias (IISPA) , Oviedo , Spain., Prieto B; d Biochemistry Laboratory , Hospital Universitario Central de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias (IISPA) , Oviedo , Spain., García-García M; d Biochemistry Laboratory , Hospital Universitario Central de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias (IISPA) , Oviedo , Spain., García-Hernández P; d Biochemistry Laboratory , Hospital Universitario Central de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias (IISPA) , Oviedo , Spain., Martín-Sánchez FJ; e Department of Emergency , Hospital Clínico San Carlos, Universidad Complutense de Madrid , Madrid , Spain., Jacob J; f Department of Emergency , Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat , Barcelona , Catalonia , Spain., Ríos J; g Laboratory of Biostatistics and Epidemiology , Universitat Autonoma de Barcelona; Medical Statistics Core Facility, IDIBAPS, Hospital Clinic , Barcelona , Catalonia , Spain., Romero R; h Department of Emergency Department , Hospital de Getafe , Madrid , Spain., Gil V; a Department of Emergency , Hospital Clínic, Barcelona; 'Emergencies: processes and pathologies' Research Group, IDIBAPS, University of Barcelona , Barcelona , Catalonia , Spain., Gayat É; b The Global REsearch on Acute conditions Team (GREAT) network.; i U942 INSERM, Department of Anesthesiology and Critical Care Medicine , Saint Louis Lariboisière University Hospital, Université Paris Diderot , Paris , France., Llorens P; j Department of Emergency, Home Hospitalization and Short Stay Unit , Hospital General de Alicante , Alicante , Spain., Mebazaa A; b The Global REsearch on Acute conditions Team (GREAT) network.; i U942 INSERM, Department of Anesthesiology and Critical Care Medicine , Saint Louis Lariboisière University Hospital, Université Paris Diderot , Paris , France.

Journal Article; Multicenter Study , 2018

Outbreaks of health care-associated influenza-like illness in France: Impact of electronic notification.

Munier-Marion E; Infection Control and Epidemiology Unit, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France., Bénet T; Infection Control and Epidemiology Unit, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France; Emerging Pathogens Laboratory-Fondation Mérieux, Centre International de Recherche en Infectiologie, Institut national de la santé et de la recherche médicale U1111, Centre National de la Recherche Scientifique UMR5308, Ecole Normale Supérieure de Lyon, Université Claude Bernard 1, Lyon, France; Institut national de la santé et de la recherche médicale, French Clinical Research Infrastructure Network, I-Innovative Clinical Research Network In Vaccinology, Lyon Collaborative Center, Lyon, France., Dananché C; Emerging Pathogens Laboratory-Fondation Mérieux, Centre International de Recherche en Infectiologie, Institut national de la santé et de la recherche médicale U1111, Centre National de la Recherche Scientifique UMR5308, Ecole Normale Supérieure de Lyon, Université Claude Bernard 1, Lyon, France; Infection Control and Epidemiology Unit, Croix Rousse Hospital, Hospices Civils de Lyon, Lyon, France., Soing-Altach S; Santé publique France, Saint-Maurice, France., Maugat S; Santé publique France, Saint-Maurice, France., Vaux S; Santé publique France, Saint-Maurice, France., Vanhems P; Infection Control and Epidemiology Unit, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France; Emerging Pathogens Laboratory-Fondation Mérieux, Centre International de Recherche en Infectiologie, Institut national de la santé et de la recherche médicale U1111, Centre National de la Recherche Scientifique UMR5308, Ecole Normale Supérieure de Lyon, Université Claude Bernard 1, Lyon, France; Institut national de la santé et de la recherche médicale, French Clinical Research Infrastructure Network, I-Innovative Clinical Research Network In Vaccinology, Lyon Collaborative Center, Lyon, France. Electronic address: philippe.vanhems@chu-lyon.fr.

Journal Article , 2017